HIF1A and breast cancer: By binding to a responsive element in the CD73 promotor, stabilized HIF1A has been reported to increase CD73 expression in human intestinal epithelial cells24 and breast cancer cell lines25, raising the possibility that increased expTreg CD73 expression may be intrinsically linked to their altered metabolic state, and potentially driven by HIF1A.